Transcription of KDIGO Clinical Practice Guideline for …
{{id}} {{{paragraph}}}
Official Journal of the International Society of Nephrology KDIGO Clinical Practice Guideline for glomerulonephritis volume 2 | issue 2 | JUNE 2012. KDIGO Clinical Practice Guideline for glomerulonephritis KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Belo Foundation, Coca-Cola Company, Dole Food Company, Genzyme, Hoffmann-LaRoche, JC Penney, NATCO The Organization for Transplant Professionals, NKF-Board of Directors, Novartis, Robert and Jane Cizik Foundation, Roche, Shire, Transwestern Commercial Services, and Wyeth. Sponsorship Statement: KDIGO is supported by a consortium of sponsors and no funding is accepted for the development of specific guidelines . contents & 2012 KDIGO . VOL 2 | SUPPLEMENT 2 | JUNE 2012. KDIGO Clinical Practice Guideline for glomerulonephritis v Tables vi KDIGO Board Members vii Reference Keys viiii Abbreviations and Acronyms 139 Notice 140 Foreword 141 Work Group Membership 142 Abstract 143 Summary of Recommendation Statements 154 Chapter 1: Introduction 156 Chapter 2: General principles in the management of glomerular disease 163 Chapter 3: Steroid-sensitive nephrotic syndrome in children 172 Chapter 4: Steroid-resistant nephrotic syndrome in children 177 Chapter 5: Minimal-change disease in adults 181 Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults 186 Chapter 7: Idiopathic membranous nephropathy 198 Chapter 8: Idiopathic membranoprolifer
KDIGO Clinical Practice Guideline for Glomerulonephritis KDIGO gratefully acknowledges the following consortium of sponsors …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}